Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo.

Grimes PE, Hamzavi I, Lebwohl M, Ortonne JP, Lim HW.

JAMA Dermatol. 2013 Jan;149(1):68-73. doi: 10.1001/2013.jamadermatol.386.

PMID:
23407924
2.

Efficacy and Safety of 308-nm Monochromatic Excimer Lamp Versus Other Phototherapy Devices for Vitiligo: A Systematic Review with Meta-Analysis.

Lopes C, Trevisani VF, Melnik T.

Am J Clin Dermatol. 2016 Feb;17(1):23-32. doi: 10.1007/s40257-015-0164-2. Review.

PMID:
26520641
3.

Vitiligo. Pathogenesis and treatment.

Njoo MD, Westerhof W.

Am J Clin Dermatol. 2001;2(3):167-81. Review.

PMID:
11705094
4.

Effectiveness of a 308-nm excimer laser in treatment of vitiligo: a review.

Alhowaish AK, Dietrich N, Onder M, Fritz K.

Lasers Med Sci. 2013 May;28(3):1035-41. doi: 10.1007/s10103-012-1185-1. Epub 2012 Aug 15. Review.

PMID:
22892613
5.

A review of monochromatic excimer light in vitiligo.

Park KK, Liao W, Murase JE.

Br J Dermatol. 2012 Sep;167(3):468-78. doi: 10.1111/j.1365-2133.2012.11008.x. Epub 2012 Aug 8. Review.

PMID:
22524428
6.

Ultraviolet-based therapy for vitiligo: what's new?

Hamzavi IH, Lim HW, Syed ZU.

Indian J Dermatol Venereol Leprol. 2012 Jan-Feb;78(1):42-8. doi: 10.4103/0378-6323.90945. Review.

7.

Exploring the gaps in the evidence-based application of narrowband UVB for the treatment of vitiligo.

Madigan LM, Al-Jamal M, Hamzavi I.

Photodermatol Photoimmunol Photomed. 2016 Mar;32(2):66-80. doi: 10.1111/phpp.12228. Epub 2016 Jan 29. Review.

PMID:
26662644
8.

Afamelanotide: A Review in Erythropoietic Protoporphyria.

Kim ES, Garnock-Jones KP.

Am J Clin Dermatol. 2016 Apr;17(2):179-85. doi: 10.1007/s40257-016-0184-6. Review.

PMID:
26979527
9.

Trends in Regenerative Medicine: Repigmentation in Vitiligo Through Melanocyte Stem Cell Mobilization.

Birlea SA, Costin GE, Roop DR, Norris DA.

Med Res Rev. 2016 Dec 28. doi: 10.1002/med.21426. [Epub ahead of print] Review.

PMID:
28029168
10.

Repigmentation through Melanocyte Regeneration in Vitiligo.

Birlea SA, Goldstein NB, Norris DA.

Dermatol Clin. 2017 Apr;35(2):205-218. doi: 10.1016/j.det.2016.11.015. Review.

PMID:
28317529
11.

Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders.

Minder EI, Barman-Aksoezen J, Schneider-Yin X.

Clin Pharmacokinet. 2017 Jan 6. doi: 10.1007/s40262-016-0501-5. [Epub ahead of print] Review.

PMID:
28063031
12.

Effect of topical calcineurin inhibitors as monotherapy or combined with phototherapy for vitiligo treatment: a meta-analysis.

Dang YP, Li Q, Shi F, Yuan XY, Liu W.

Dermatol Ther. 2016 Mar-Apr;29(2):126-33. doi: 10.1111/dth.12295. Epub 2015 Oct 13. Review.

PMID:
26460804
13.

Vitiligo: symptoms, pathogenesis and treatment.

Ghafourian A, Ghafourian S, Sadeghifard N, Mohebi R, Shokoohini Y, Nezamoleslami S, Hamat RA.

Int J Immunopathol Pharmacol. 2014 Oct-Dec;27(4):485-9. Review.

PMID:
25572727
14.

Medical and Maintenance Treatments for Vitiligo.

Passeron T.

Dermatol Clin. 2017 Apr;35(2):163-170. doi: 10.1016/j.det.2016.11.007. Review.

PMID:
28317526
15.

Vitiligo Pathogenesis and Emerging Treatments.

Rashighi M, Harris JE.

Dermatol Clin. 2017 Apr;35(2):257-265. doi: 10.1016/j.det.2016.11.014. Review.

PMID:
28317534
16.

Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review.

Habbema L, Halk AB, Neumann M, Bergman W.

Int J Dermatol. 2017 Mar 7. doi: 10.1111/ijd.13585. [Epub ahead of print] Review.

PMID:
28266027

Supplemental Content

Support Center